Bibliography
| 1978 | 1979|
| 1980 | 1981 | 1982
| 1983 | 1984 | 1985
| 1986 | 1987 | 1988
| 1989 |
| 1990 | 1991 | 1992
| 1993 | 1994 | 1995
| 1996 | 1997 | 1998
| 1999 |
| 2000 | 2001 | 2002
| 2003 | 2004 | 2005
| 2006 |
1978
1. Saikku P, Paavonen J: Single-antigen immunofluorescence test for
chlamydial antibodies. J Clin Microbiol 8:119-22, 1978. IF 3.964
2. Paavonen J, Kousa M, Saikku P, Vesterinen E, Jansson E, Lassus A:
Examination of men with nongonococcal urethritis and their sexual partners
for Chlamydia trachomatis and Ureaplasma urealyticum. Sex Transm Dis
5:93-6, 1978. IF 1.894
3. Paavonen J, Saikku P, Vesterinen E, Meyer B, Vartiainen E, Saksela
E: Genital chlamydial infections in patients attending a gynecological
outpatient clinic. Br J Vener Dis 54:257-61, 1978. IF 1.604
4. Vesterinen E, Vaheri A, Paavonen J, Saksela E: Adenovirus infection
and cytopathic alterations of cervical human epithelial cells in vitro.
Acta Cytol 22:566-69, 1978. IF 0.987
1979
5. Paavonen J, Vesterinen E, Meyer B, Saikku P, Suni J, Purola E, Saksela
E: Genital Chlamydia
trachomatis infections in patients with cervical atypia. Obstet Gynecol
54:289-91, 1979. IF 2.427
6. Paavonen J: Chlamydia trachomatis-induced urethritis in female partners
of men with nongonococcal urethritis. Sex Transm Dis 6:69-71, 1979.
IF 1.894
7. Paavonen J: Chlamydial infections. Microbiological, clinical, and
diagnostic aspects. Med Biol 57:135-51, 1979. IF 1.716
8. Paavonen J, Saikku P, Vesterinen E, Aho K: Chlamydia trachomatis
in acute salpingitis. Br J Vener Dis 55:203-6, 1979. IF 1.604
9. Lassus A, Paavonen J, Kousa M, Saikku P: Erythromycin and lymecycline
treatment in chlamydia- positive and chlamydia-negative non-gonococcal
urethritis - A partner controlled study. Acta Dermatovener (Stockholm)
59:278-82, 1979. IF 1.076
10. Paavonen J, Saikku P, Vesterinen E, Lehtovirta P: Infertility and
cervical Chlamydia trachomatis infections. Acta Obstet Gynecol Scand
58:301-3, 1979.IF 0.872
11. Paavonen J: Chlamydia trachomatis infections in the female genital
tract. Academic dissertation. University Central Hospital, Helsinki,
1979. ISBN 951-451730-X.
1980
12. Paavonen J, Meyer B, Vesterinen E, Saksela E: Colposcopic and histological
findings in cervical chlamydial infection. Lancet ii:320, 1980 (letter,
peer reviewed). IF 17.948
13. Paavonen J: Chlamydia trachomatis in acute salpingitis. Am J Obstet
Gynecol 138:957-9, 1980. IF 2.642
14. Laatikainen T, Apter D, Paavonen J, Wahlström T: Steroids in
ovarian and peripheral venous
blood in polycystic ovarian disease. Clin Endocrinol 13:125-34, 1980.
IF 2.414
15. Paavonen J, Purola E: Cytologic findins in cervical chlamydial infection.
Med Biol 58:174-8, 1980. IF 1.716
16. Paavonen J, Kousa M, Saikku P, Kanerva L, Vartiainen E, Lassus A:
Treatment of nongonococcal urethritis with trimethoprim-sulphadiazine
and with placebo. A double-blind partner-controlled study. Br J Vener
Dis 56:101-4, 1980. IF 1.604
17. Paavonen J, Valtonen VV: Chlamydia trachomatis as a possible cause
of peritonitis and perihepatitis in a young woman. Br J Vener Dis 56:341-3,
1980. IF 1.604
18. Paavonen J, Vesterinen E: Intrauterine contraceptive device use
in patients with acute salpingitis. Contraception 22:107-14, 1980. IF
0.865
19. Paavonen J, Kajanoja P, Larinkari U, Purola E: Susceptibility of
abortion patients to infection: Correlation to cervical flora. Int J
Gynecol Obstet 18:44-7, 1980. IF 0.387
1981
20. Paavonen J, Valtonen VV, Malkamäki M, Kasper DL, Mäkelä
PH: Serological evidence for the role of Bacteroides fragilis and Enterobacteriaceae
in the pathogenesis of acute pelvic inflammatory disease. Lancet i:293-5,
1981. IF 17.948
21. Paavonen J, Saikku P, Wang S-P, von Knorring J, Aho K: Association
of infection with Chlamydia trachomatis with Fitz-Hugh-Curtis Syndrome.
J Infect Dis 144:176, 1981. IF 5.418
1982
22. Keski-Oja J, Paavonen J: Isolation of Chlamydia trachomatis in untreated
MMC-E mouse epithelial cells. J Clin Microbiol 1 6:391-94, 1982. IF
3.964
23. Paavonen J, Meyer B, Vesterinen E, Saksela E: Colposcopic and histologic
findings in cervical chlamydial infection. Obstet Gynecol 59:712-15,
1982. IF 2.427
24. Koskimies AI, Paavonen J, Meyer B, Kajanoja P: Cervicitis and infertility.
Am J Reprod Immunol 1:299-302, 1982. IF 1.942
25. Paavonen J, Vesterinen E: Chlamydia trachomatis in cervicitis and
urethritis in women. Scand J Infect Dis 32(Suppl):45-54, 1982. IF 1.147
26. Purola E, Paavonen J: Routine cytology as a diagnostic aid in chlamydial
cervicitis. Scand J Infect Dis 32(Suppl): 55-8, 1982. IF 1.147
27. Paavonen J, Vesterinen E, Mårdh P-A: Infertility as a sequela
of chlamydial pelvic inflammatory disease. Scand J Infect Dis 32(Suppl):
73-6, 1982. IF 1.147
28. Paavonen J, Brunham R, Kiviat N, Stevens C, Kuo CC, Stamm WE, Holmes
KK: Cervicitis -
etiologic, clinical, and histopathologic findings. In: Chlamydial Infections.
P-A Mårdh, KK Holmes, JD Oriel, P Piot (Eds.) Fernström Foundation
Series, Elsevier Biomedical Press, Amsterdam, The Netherlands, 1982:141-5.
29. Paavonen J, Brunham RC, Kiviat N, Stevens C, Kuo C-C, Stamm W, Holmes
K, Eschenbach DA: Clinical and histologic evidence of endometritis among
women with cervicitis. P-A Mårdh, KK Holmes, JD Oriel, P Piot
(Eds.), Fernström Foundation Series, Elsevier Biomedical Press,
Amsterdam, The Netherlands, 1982:1 63-7.
30. Paavonen J: Chlamydial infections of the female genital tract and
the neonate. Part 1. Infect Dis Letters Obstet Gynecol 4:19-24, 1982.
31. Paavonen J: Chlamydial infections of the female genital tract and
neonate. Part 11. Infect Dis Letters Obstet Gynecol 4:25-30, 1982.
1983
32. Saikku P, Paavonen J, Väänänen P, Vaheri A: Solid-phase
enzyme immunoassay for chlamydial antibodies. J Clin Microbiol 17:22-27,
1983. IF 3.964
33. Paavonen J, Miettinen A, Stevens CE, Chen KCS, Holmes KK: Mycoplasma
hominis in nonspecific vaginitis. Sex Transm Dis 10 (Suppl):271-5, 1983.
IF 1.894
34. Miettinen A, Paavonen J, Jansson E, Leinikki P: Enzyme immunoassay
for serum antibody to Mycoplasma hominis in women with acute pelvic
inflammatory disease. Sex Transm Dis 10 (Suppl):289-93, 1983. IF 1.894
35. Paavonen J, Miettinen A, Stevens CE, Kiviat N, Kuo C-C, Stamm WE,
Holmes KK: Mycoplasma hominis in cervicitis and endometritis. Sex Transm
Dis 10(Suppl):276-80, 1983. IF 1.894
36. Paavonen J: Physiology and ecology of the vagina. Scand J Infect
Dis (Suppl) 40:31-35, 1983. IF 1.147
1984
37. Brunham RC, Paavonen J, Stevens CE, Kiviat N, Kuo C-C, Critchlow
CV, Holmes KK: Mucopurulent cervicitis -The ignored counterpart in women
of urethritis in men. N Engl J Med 311:1-6, 1984. IF 24.834
38. Miettinen A, Paavonen J, Turunen H, Jansson E, Leinikki P: Detection
of Mycoplasma hominis antigen in clinical specimens by using a four-layer
modification of enzyme immunoassay (EIA). J lmmunol Methods 69:267-75,
1984. IF 1.883
39. Heinonen PK, Merikari M, Paavonen J: Uterine perforation by copper
intrauterine device. Eur J Obstet Gynec Reprod Biol 17:257-61,1984.
IF 0.537
40. Lehtinen M, Lehtinen T, Koivisto V, Paavonen J, Leinikki P: Purification
of herpes simplex virus- specified major DNA-binding proteins and detection
of antibodies to them in human and rabbit sera. Acta Virol 28:448-56,
1984. IF 0.481
41. Paavonen J: Therapy of bacterial vaginosis. Scand J Urol Nephrol
86:265-66, 1984. IF 0.470
42. Paavonen J, Jouttunpää K, Kangasluoma P, Heinonen PK:
Velamentous insertion of the umbilical cord and vasa previa. lnt J Gynecol
Obstet 22:207-11, 1984. IF 0.387
43. Paavonen J, Aine R, Heinonen PK, Teisala K, Punnonen R, Lehtinen
M, Miettinen A, Grönroos P: Etiology and manifestations of acute
pelvic inflammatory disease: Use of laparoscopic and endometrial sampling.
Infertility 7:21 5-35, 1984.
44. Briggs R, Paavonen J: Cervical intraepithelial neoplasia.ln: Sexually
Transmitted Diseases KK Holmes et al (toim), McGraw-Hill Book Co., New
York, 1984:589-615. ISBN 0-07-029675-8.
45. Paavonen J, Berg M, Lahtinen M, Heinonen PK: Diagnostic laparoscopy
in primary infertility. Proc XI World Congr Fertil Steril 31:167-70,
1984.
1985
46. Kiviat N, Paavonen J, Brockway J, Critchlow C, Brunham RC, Stevens
CE, Stamm WE, Kuo C-C, DeRouen T, Holmes KK: Cytologic manifestations
of cervical and vaginal infections. 1. Epithelial and inflammatory cellular
changes. JAMA 253:989-96, 1985. IF 9.277
47. Lehtinen M, Rantala 1, Teisala K, Heinonen PK, Lehtinen T, Aine
R, Miettinen A, Grönroos P, Punnonen R, Leinikki P, Paavonen J:
Detection of herpes simplex virus in women with acute pelvic inflammatory
disease. J Infect Dis 152:78-82, 1985. IF 5.418
48. Lehtinen M, Koivisto V, Paavonen J, Lehtinen T, Leinikki P: Serum
antibodies to the major HSV-2 specified DNA-binding protein in patients
with an acute HSV infection or cervical neoplasia. J Med Virol 16:245-56,
1985. IF 2.792
49. Paavonen J, Lehtinen M, Teisala K, Heinonen PK, Punnonen R, Aine
R, Miettinen A, Grönroos P: Haemophilus influenzae causes purulent
salpingitis. Am J Obstet Gynecol 151:338-9, 1985. IF 2.642
50. Paavonen J, Kiviat N, Brunham RC, Stevens CE, Kuo C-C, Stamm WE,
Miettinen A, Soules M, Eschenbach DA, Holmes KK: Prevalence and manifestations
of endometritis among women with cervicitis. Am J Obstet Gynecol 152:280-6,
1985. IF 2.642
51. Paavonen J, Aine R, Teisala K, Heinonen PK, Punnonen R: Comparison
of endometrial biopsy and peritoneal fluid cytologic testing with laparoscopy
in the diagnosis of acute pelvic inflammatory disease. Am J Obstet Gynecol
151: 645-50, 1985. IF 2.642
52. Paavonen J, Teisala K, Heinonen PK, Aine R, Miettinen A, Lehtinen
M, Grönroos P: Endometritis and acute salpingitis associated with
Chlamydia trachomatis and herpes simplex virus type two. Obstet Gynecol
65:288-91, 1985. IF 2.427
53. Heinonen PK, Teisala K, Punnonen R, Miettinen A, Lehtinen M, Paavonen
J: Anatomic sites of upper genital tract infection. Obstet Gynecol 66:384-90,
1985. IF 2.427
54. Paavonen J, Aine R, Teisala K, Heinonen PK, Punnonen R, Lehtinen
M, Miettinen A, Grönroos P: Chlamydial endometritis. J Clin Pathol
138:726-32, 1985. IF 1.581
55. Lehtinen M, Koivisto V, Paavonen J, Lehtinen T, Leinikki P: lmmunoblotting
and enzyme-linked immunosorbent assay analysis of serological responses
in patients infected with herpes simplex virus types 1 and 2. lntervirology
24:1 8-25, 1985. IF 1.054
56. Paavonen J, Vesterinen E, Purola E, Jokipii AMM, Jokipii L, Hoittinen
K, Vartiainen E: Single dose of tinidazole in the treatment of vaginal
discharge. Scand J Urol Nephrol S86:237-40, 1984. IF 0.470
57. Paavonen J, Vesterinen E, Aantaa K, Räsänen J: Factors
predicting abnormal hysterosalpingographic findings in patients treated
for acute pelvic inflammatory disease. lnt J Gynecol Obstet 23:171-175,
1985. IF 0.387
58. Paavonen J, Varjonen-Toivonen M, Komulainen M, Heinonen PK: Diagnosis
and management of tubal pregnancy: Effect on fertility outcome. lnt
J Gynecol Obstet 23:129-33, 1985. IF 0.387
59. Paavonen J: Mucopurulent cervicitis: An often ignored STD. Human
Sexual 19:132-40, 1985.
60. Paavonen J: Chlamydia and infertility. Syva Monitor 3:1-4, 1985.
61. Paavonen J: Colposcopic findings associated with human papillomavirus
infections of the vagina and cervix. Obstet Gynecol Surv 40:1 85-9,
1985.
62. Paavonen J, Mäkelä PH: Use of serologic methods in the
diagnosis of pelvici inflammatory disease. In: Infections in Reproductive
Health, LG Keith et al (toim), MTP Press Ltd., England, Vol 1, Chapter
15, 1985:209-236.
63. Vesterinen E, Purola E, Paavonen J: Cytological diagnosis of cervical
infections. In: Infections in Reproductive Health, LG Keith et al (toim),
MTP Press Ltd., England, Vol 1, Chapter 4, 1985:75-1 00.
1986
64. Wölner-Hanssen P, Eschenbach D, Paavonen J, Holmes KK: Treatment
of pelvic inflammatory disease: Use doxycycline with an appropriate
beta-lactam while we wait for better data. JAMA 256:3262-3, 1986. IF
9.277
65. Lehtinen M, Rantala I, Aine R, Miettinen A, Laine S, Heinonen P,
Teisala K, Punnonen R, Paavonen J: B cell response in Chlamydia trachomatis
endometritis. Eur J Clin Microbiol 5:596-8, 1986. IF 3.964
66. Puolakkainen M, Vesterinen E, Purola E, Saikku P, Paavonen J: Persistence
of chlamydial antibodies after pelvic inflammatory disease. J Clin Microbiol
23:9248, 1986. IF 3.964
67. Räsänen L, Lehtinen M, Lehto M, Paavonen J, Leinikki P:
Polyclonal response of human lymphocytes to Chlamydia trachomatis. Infect
lmmun 54:28-31, 1986. IF 3.928
68. Lehtinen M, Laine S, Heinonen PK, Teisala K, Miettinen A, Aine R,
Punnonen R, Grönroos P, Paavonen J: Serum C-reactive protein determination
in acute pelvic inflammatory disease. Am J Obstet Gynecol 154:158-9,
1986. IF 2.642
69. Kiviat N, Wölner-Hanssen P, Peterson M, Wasserheit J, Stamm
WE, Eschenbach DA,Paavonen J, Lingenfelter J, Bell T, Zabriskie V, Kirby
B, Holmes KK: Localization of Chlamydia trachomatis infection by direct
immunofluorescence and culture in pelvic inflammatory disease. Am J
Obstet Gynecol 154:865-73, 1986. IF 2.642
70. Paavonen J, Critchlow CW, DeRouen T, Kiviat N, Stevens CE, Brunham
RC, Stamm WE, Kuo CC, Hyde KE, Corey L, Eschenbach DA, Holmes KK: Etiology
of cervical inflammation. Am J Obstet Gynecol 154:556-64, 1986. IF 2.642
71. Miettinen A, Saikku P, Jansson E, Paavonen J: Epidemiologic and
clinical characteristics of pelvic inflammatory disease associated with
Mycoplasma hominis, Chlamydia trachomatis, or Neisseria gonorrhoeae.
Sex Transm Dis 13:24-8, 1986. IF 1.894
72. Paavonen J, Heinonen PK, Aine R, Laine S, Grönroos P: Prevalence
of nonspecific vaginitis and other cervicovaginal infections during
the third trimester of pregnancy. Sex Transm Dis 13:5-8, 1986. IF 1.894
73. Heinonen PK, Teisala K, Punnonen R, Aine R, Lehtinen M, Miettinen
A, Paavonen J: Treating of pelvic inflammatory disease with doxycycline
and metronidazole or penicillin and metronidazole. Genitourin Med 62:235-9,
1986. IF 1.604
74. Jokipii AMM, Jokipii L, Vesterinen E, Purola E, Vartiainen E, Paavonen
J: Volatile fatty acid findings in vaginal fluid compared with symptoms,
signs, other laboratory results, and susceptibility to tinidazole of
malodorous vaginal discharges. Genitourin Med 62:102-6, 1986. IF 1.604
75. Kiviat N, Paavonen J, Wölner-Hanssen P, Critchlow C, DeRouen
T, Douglas J, Stevens C, Holmes KK: Histologic manifestations of chlamydial
cervicitis. D Oriel, G Ridgway, J Schachter, D Taylor- Robinson (Eds.).
Chlamydial Infections. Cambridge University Press. Great Britain, 1986:209-12.
76. Paavonen J, Stevens CE, Wölner-Hanssen P, Kiviat N, Critchlow
C, DeRouen T, Koutsky L, Holmes KK: Colposcopic diagnosis of cervical
and vaginal infections. D Oriel, G Ridgway, J Schachter, D Taylor-Robinson
(Eds.). Chlamydial Infections. Cambridge University Press. Great Britain,
1986:213-6.
1987
77. Teisala K, Heinonen PK, Aine R, Punnonen R, Paavonen J: Second laparoscopy
after
treatment of acute pelvic inflammatory disease. Obstet Gynecol 69:343-6,
1987. IF 2.427
78. Paavonen J, Teisala K, Heinonen PK, Aine R, Laine S, Lehtinen M,
Miettinen A,
Punnonen R, Grönroos P: Microbiological and histopathological findings
in acute pelvic inflammatory disease. Br J Obstet Gynecol 94:454-60,
1987. IF 2.219
79. Paavonen J, Stamm WE: Lower genital tract infections in women. Infect
Dis Clin
North America 1:179-98, 1987. IF 1.046
1988
80. Wölner-Hanssen P, Paavonen J, Kiviat N, Landers D, Sweet RL,
Eschenbach DA, Holmes KK: Ambulatory treatment of pelvic inflammatory
disease with Augmentin, with or without doxycycline. Am J Obstet Gynecol
158:577-9, 1988. IF 2.642
81. Wölner-Hanssen P, Paavonen J, Kiviat N, Young M, Eschenbach
DA, Holmes KK: Outpatient treatment of pelvic inflammatory disease with
cefoxitin and doxycycline. Obstet Gynecol 71:595-600, 1988. IF 2.427
82. Gökhan C, Puolakkainen M, Paavonen J, lmmonen A, Parkhede U,
Wetterlund S, Saikku
P: Comparison of new enzyme immunoassay with direct immunofluorescence
and chlamydial isolation in detection of genital Chlamydia trachomatis
infection. Proc Eur Soc Chlamydia Res. University of Bologna, 1988,
p. 245.
83. Miettinen A, Heinonen PK, Teisala K, Lehtinen M, Kahma K, Aine R,
Grönroos P, Punnonen R, Paavonen J: Antigen-specific antibody response
to Chlamydia trachomatis in patients with pelvic inflammatory disease.
Proc Eur Soc Chlamydia Res. The University of Bologna, 1988: 274.
84. Paavonen J: Clinical manifestations and therapy of genital chlamydial
infections in women. Proc Europ Soc Chlamydia Res The University of
Bologna, 1988:151 -55.
85. Paavonen J, Kiviat N, Wölner-Hanssen P, Stevens CE, Critchlow
CW, DeRouen T, Koutsky L, Stamm WE, Corey L, Holmes KK: Colposcopic
manifestations of cervical and vaginal infections. Obstet Gynecol Surv
43:373-81, 1988.
86. Paavonen J, Lehtinen M, Laine S, Aaran R, Miettinen A, Heinonen
PK, Teisala K, Aine R, Punnonen R, Stenman U: High rate of elevated
serum levels of CA 1 25 and TATI in acute pelvic inflammatory disease.
Proc Eur Soc Chlamydia Res. The University of Bologna, 1988:181.
87. Paavonen J, Laine S, Aaran RK, Miettinen A, Heinonen PK, Teisala
K, Aine R, Punnonen R, Stenman U-H, Lehtinen M: Comparison of serum
CA 125 and CRP determinations in predicting the severity of acute pelvic
inflammatory disease. In: Proceedings of the XXVI World Congress of
International College of Surgenos. M Montorsi, P Granelli (eds.). Monduzzi
Editore, Bologna, Italy. X. Urology and Gynecology, 1988:493-7.
1989
88. Kiviat N, Koutsky L, Paavonen J, Galloway D, Critchlow C, Beckmann
A-M, McDougall J, Peterson M, Stevens C, Lipinski C, Holmes KK: Prevalence
of genital papillomavirus infection among women attending a college
student health clinic or a sexually transmitted disease clinic. J Infect
Dis 159:293-302, 1989. IF 5.418
89. Paavonen J, Lehtinen M, Laine S, Lehto M, Aine R, Räsänen
L, Stenman U-H: Concentrations of tumor-associated trypsin inhibitor
and C-reactive protein in serum in acute pelvic inflammatory disease.
Clin Chem 35:869-871, 1989. IF 3.422
90. Lehtinen M, Hakama M, Knekt P, Heinonen PK, Lehtinen T, Paavonen
J, Teppo L, Leinikki P: Lack of serum antibodies to the major HSV-2
specified DNA-binding protein before diagnosis of cervical neoplasia.
J Med Virol 27:1 31-6, 1989. IF 2.792
91. Paavonen J, Roberts PL, Stevens CE, Stamm WE, Kuo CC, Wölner-Hanssen
P, Brunham RC, Hillier S, DeRouen T, Holmes KK, Eschenbach DA: Randomized
treatment of mucopurulent cervicitis with doxycycline or amoxicillin.
Am J Obstet Gynecol 161:1 28-135, 1989. IF 2.642
92. Paavonen J, Miettinen A, Heinonen PK, Aaran RK, Teisala K, Aine
R, Punnonen R, Laine S, Kallioniemi OP, Lehtinen M: Serum CA 125 in
acute pelvic inflammatory disease. Br J Obstet Gynecol 96:574-579, 1989.
IF 2.219
93. Miettinen A, Hakkarainen K, Grönroos P, Heinonen P, Teisala
K, Aine R, Sillantaka I, Saarenmaa K, Punnonen R, Lehtinen M, Paavonen
J: Class specific antibody response to gonococcal infection. J Clin
Pathol 42:72-76, 1989. IF 1.581
94. Lehtinen M, Kulomaa P, Kallioniemi OP, Paavonen J, Leinikki P: Analysis
of DNA synthesis in herpes simplex virus infected cells by dual parameter
flow cytometry. Arch Virol 107:215-23, 1989. IF 1.498
95. Paavonen J, Kiviat N, WöIner-Hanssen P, Stevens CE, Vontver
LA, Brockway J, Critchlow C, DeRouen T, Holmes KK: Significance of mild
cervical cytologic atypia in a sexually transmitted disease clinic population.
Acta Cytol 33:831-38, 1989. IF 0.987
96. Giacomini G, Paavonen J, Rilke F: Microbiologic classification of
cervicovaginal flora in Papanicolaou smears. Acta Cytol 33:277-278,
1989 (letter, peer reviewed). IF 0.987
97. Lehtinen M, Koivisto V, Lehtinen T, Ylä-Outinen A, Romppanen
U, Paavonen J: lmmunoblotting analysis of class-specific antibody response
in patients with primary HSV infection. Acta Virol 33:8-14, 1989. IF
0.481
98. Punnonen R, Lehtinen M, Heinonen PK, Teisala K, Aine R, Rantala
I, Miettinen A, Laine S, Paavonen J: The relation between serum sex
steroid levels and plasma cell infiltrates in endometritis. Arch Gynecol
Obstet 244:1 85-191, 1989. IF 0.166
99. Mårdh PA, Paavonen J, Puolakkainen M: Chlamydia. Plenum Publishing
Corporation, New York, 1989 (370 pages). ISBN 0-306-42965-9.
100. Paavonen J: The 3rd international conference on human papillomaviruses
and squamous carcinoma. lnterferons and Cytokines, April 1989 (10):20-23.
1990
101. Wölner-Hanssen P, Eschenbach DA, Paavonen J, Kiviat N, Stevens
CE, Critchlow C, DeRouen T, Holmes KK: Decreased risk of symptomatic
chlamydial pelvic inflammatory disease associated with oral contraceptive
use. JAMA 263:54-59, 1990. IF 9.277
102. WöIner-Hanssen P, Eschenbach DA, Paavonen J, Kiviat N, Stevens
CE, Critchlow C, DeRouen T, Koutsky L, Holmes KK: Association between
vaginal douching and acute pelvic inflammatory disease. JAMA 263:1936-41,
1990. IF 9.277
103. Ranki M, Leinonen AW, Jalava T, Paavonen J, Nieminen P, Soares
VRX, Kallio A: Use of Affiprobe HPV test kit for detection of human
papillomavirus DNA in genital scrapes. J Clin Microbiol 28:2076-81,
1990. IF 3.964
104.Kiviat N, Wölner-Hanssen P, Eschenbach DA, Wasserheit J, Paavonen
J, Bell TA, Critchlow CW, Stamm WE, Moore DE, Holmes KK: Endometrial
histopathology in patients with culture-proved upper genital tract infection
and laparoscopically diagnosed acute salpingitis. Am J Surg Pathol 14:1
67-75, 1990. IF 3.797
105. Kiviat N, Paavonen J, WöIner-Hanssen P, Critchlow CW, Stamm
WE, Douglas J, Eschenbach DA, Corey LA, Holmes KK: Histopathology of
endocervical infection caused by Chlamydia trachomatis, herpes simplex
virus, Trichomonas vaginalis, and Neisseria gonorrhoeae. Human Pathol
21:831-7, 1990. IF 3.659
106. Leminen A, Paavonen J, Wahlström T, Forss M, Vesterinen E:
Adenocarcinoma of the uterine cervix. Cancer 65:53-9, 1990. IF 3.296
107. Lehtinen M, Parkkonen P, Niemelä J, Paavonen J: Demonstration
of evolutionary differences between conserved antigenic epitopes in
the minor nucleocapsid protein of human papillomavirus types 6b, 16,
and 18. Biochem Biophys Res Communic 172:1 378-83, 1990. IF 2.872
108. Leminen A, Paavonen J, Vesterinen E, Forss M, Wahlström T,
Kulomaa P, Lehtinen M: Deoxyribonucleic acid flow cytometric analysis
of cervical adenocarcinoma: prognostic significance of deoxyribonucleic
acid ploidy and S-phase fraction. Am J Obstet Gynecol 162:848-53, 1990.
IF 2.642
109. Sellors JW, Nieminen P, Vesterinen E, Paavonen J: Observer variability
in the scoring of colpophotographs. Obstet Gynecol 76:1006-8, 1990.
IF 2.427
110. Paavonen J: Subcutaneous interferon alpha in the treatment of refractory
condylomata. Sex Transm Dis 17:1 52-3, 1990. IF 1.894
111. Miettinen A, Heinonen, Teisala K, Punnonen R, Paavonen J: Antigen
specific serum antibody response to Chlamydia trachomatis in patients
with acute pelvic inflammatory disease. J Clin Pathol 43:758- 61, 1990.
IF 1.581
112. Soares VRX, Nieminen P, Aho M, Vesterinen E, Vaheri A, Paavonen
J: Human papillomavirus DNA in unselected pregnant and non-pregnant
women. lnt J STD & AIDS 1:276-8, 1990. IF 0.888
113. Paavonen J: Pelvic inflammatory disease. Seminars in Dermatology
9:126-132, 1990. IF 0.356
114. Kurki T, Teramo K, Ylikorkala 0, Paavonen J: C-reactive protein
in preterm rupture of the membranes. Arch Obstet Gynecol 247:31-37,
1990. IF 0.166
115. Paavonen J: Chlamydia trachomatis infections. J Exp & Clin
Cancer Res 9 (No.l, Suppl):19-23, 1990. IF 0.153
116. Ranki M, Jalava T, Raussi J, Söderlund H, Nieminen P, Paavonen
J, Kallio A: Affiprobe HPV test kit in the detection of human papillomavirus
DNA from cervical scrapes. Papillomaviruses; UCLA Symposia on Molecular
and Cellular Biology. Howley P, Broker J (eds.). Alan R. Liss Inc.,
New York, Vol. 124, pp. 109-118, 1990.
117. Lehtinen M, Parkkonen P, Luoto H, Ylä-Outinen A, Romppanen
U, Rantala I, Paavonen
J: Antipeptide IgA antibodies to a human papillomavirus type 16 E2 derived
synthetic peptide predict the natural history of cervical HPV infection.
Serono Symposia Publications from Raven Press 78:509-519, 1990.
118. Paavonen J, Cacciatore B, Leminen A, lngman-Friberg S, Ylöstalo
P: Outpatient diagnosis of pelvic inflammatory disease. In: Chlamydial
Infections. WR Bowie, HD Caldwell, RB Jones, P-A Mårdh, GL Ridgway,
J Schachter, WE Stamm, ME Ward (eds.), Cambridge University Press, 1990,
pp.307-10. ISBN 0- 521-39082-6.
119. WöIner-Hanssen P, Eschenbach DA, Paavonen J, Thorpe Jr. E,
Pettinger M, Holmes KK: Acute saipingitis: Relationship of manifestations
to infection with Chlamydia trachomatis or with Neisseria gonorrhoeae.
In: Chlamydial Infections. WR Bowie, HD Caldwell, RB Jones, P-A Mårdh,
GL Ridgway, J Schachter, WE Stamm, ME Ward (eds.), 1990, pp.311-14.
ISBN 0-521-39082-6.
120. Puolakkainen M, Linnanmäki E, Paavonen J, Leinonen M, Saikku
P: Chlamydial lipopolysaccharide containing circulating immune complexes
in pelvic inflammatory disease. In: Chlamydial Infections. WR Bowie,
HD Caldwell, RB Jones, P-A Mårdh, GL Ridgway, J Schachter, WE
Stamm, ME Ward (eds.), Cambridge University Press, 1990, pp.319-22.
ISBN 0-521-39082144
121. Ylä-Outinen A, Lehtinen M, Romppanen U, Luoto H, Rantala 1,
Paavonen J: Chlamydia trachomatis is a risk factor of persistent koilocytotic
atypia. In: Chlamydial Infections. WR Bowie, HD Caldwell, RB Jones,
P-A Mårdh, GL Ridgway, J Schachter, WE Stamm, ME Ward (eds.),
Cambridge University Press, 1990, pp.323-26. ISBN 0-521-39082-681.
122. Paavonen J: Chronic and late sequelae of pelvic inflammatory disease.
In: Pelvic Inflammatory Disease. Epidemiology, etiology, management,
complications. Hospital Practice, Special Report, August 1990. HP Publishing
Company, New York, NY. ISBN 0-913800-38-4.
123. Paavonen J, Koutsky LA, Kiviat N: Cervical neoplasia and other
STD related genital and anal neoplasias. In: Sexually Transmitted Diseases.
KK Holmes et al (eds.), McGraw-Hill Book Co., New York, 2. Edition,
1990, Chapter 48, pp. 561-592. ISBN 0-07-029677-4.
124. Paavonen J: Genital neoplasia in HIV-infected women. Archives in
AIDS Research 4:267-9, 1990.
1991
125. Aho M, Vesterinen E, Meyer B, Purola E, Paavonen J: Natural history
of vaginal intraepithelial neoplasia. Cancer 68:195-7, 1991. IF 3.296
126. Nieminen P, Soares VRX, Aho M, Vesterinen E, Savia E, Vaheri A,
Paavonen J: Cervical human papillomavirus deoxyribonucleic acid and
cytologic evaluations in gynecologic outpatients. Am J Obstet Gynecol
164:1265-9, 1991. IF 2.642
127. Landers DV, Wölner-Hanssen P, Paavonen J, Thorpe E, Kiviat
N, Ohm-Smiths M, Green JR, Schachter J, Holmes KK, Eschenbach DA, Sweet
RL: Combination antimicrobial therapy in the treatment of acute pelvic
inflammatory disease. Am J Obstet Gynecol 164:849-58, 1991. IF 2.642
128. Leminen A, Paavonen J, Vesterinen E, Wahlström T, Rantala
1, Lehtinen M: Human papillomavirus types 16 and 18 in adenocarcinoma
of the uterine cervix. Am J Clin Pathol 95:647-52, 1991. IF 2.522
129. Maw RD, Dinsmore W, Horner T, Lawther H, Rinne E, Paavonen J, Aho
M, Vesterinen E, Tuimala R, Saastamoinen J, Syrjänen S, Syrjänen
K, Walker M, Ryff JCh, Smith C, Budde M, Blackburn N, Ellmen J, Wahl
M (The Condylomata International Collaborative Study Group): A comparison
of interferon alfa-2a and podophyllin in the treatment of primary condylomata
acuminata. Genitourin Med 67:394-99, 1991. IF 1.604
130. Cone R, Beckmann A, Aho M, Wahlström T, Corey L, Ek M, Paavonen
J: Subclinical manifestations of vulvar human papillomavirus infection.
lnt J Gynecol Pathol 10:26-35, 1991. IF 1.465
131. Nieminen P, Koskimies AI, Paavonen J: Human papillomavirus DNA
is not transmitted by semen. lnt J STD & AIDS 2:207-8, 1991. IF
0.888
132. Paavonen J: General sexually transmitted diseases. Curr Opin Obstet
Gynecol 3:715-24, 1991. IF 0.663
133. Paavonen J: Chlamydia trachomatis infections in pregnancy. Contemp
Ob/Gyn 36:91-6, 1991.
134. Paavonen J, Lehtinen M: Human papillomaviruses and anogenital neoplasia.
The AIDS Reader 1:116-23, 1991.
135. Stellato G, Aho M, Nieminen P, Vesterinen E, Vaheri A, Paavonen
J: Limits of colposcopic diagnosis of papillomavirus infection: Relationship
between colposcopic manifestations and hybridization results. Cervix
and the lower female genital tract infections 9:17-20, 1991.
136. Paavonen J: Chlamydial pelvic inflammatory disease-diagnosis. In:
Chlamydial Infections of the Genital and Respiratory Tracts and Allied
Conditions. Mårdh P-A, Saikku P (eds.). Gummerus Co., Jyväskylä,
Finland, 1991, p. 172-1 83.
137. Paavonen J: Human papillomaviruses in the pathogenesis of anogenital
neoplasias. Trends in Urology 2:4-5, 1991.
138. Paavonen J: Lower genital tract neoplasia in HIV-infected patients.
The AIDS Reader 1: 176-9, 1991.
139. Vesterinen E, Paavonen J: Human papillomaviruses and neoplasias
of the uterine cervix. Sapporo Medical Journal 60:569-574, 1991.
140. Paavonen J: Does this woman with pelvic pain have PID? Uppsala
J Med Sci 50:4-7, 1991.
1992
141. Koutsky L, Holmes KK, Critchlow CW, Stevens CE, Paavonen J, Beckmann
AM, DeRouen T, Galloway DA, Vernon D, Kiviat NB: A cohort study of the
risk of cervical intraepithelial neoplasia grade 2 or 3 in relation
to papillomavirus infection. N Engl J Med 327:1272-8, 1992. IF 24.834
142. Tiitta O, Wahlström T, Paavonen J, Linnala A, Sharma S, Gould
VE, Virtanen I: Enhanced tenascin expression in cervical and vulvar
koilocytotic lesions. Am J Pathol 141:907-13, 1992. IF 7.246
143. Skogberg K, Syrjänen J, Jahkola M, Renkonen O-V, Paavonen
J, Ahonen J, Kontiainen S, Ruutu P, Valtonen V: Clinical presentation
and outcome of listeriosis in patients with and without immunosuppressive
therapy. Clin Infect Dis 14:815-21, 1992. IF 3.240
144. Lehtinen M, Leminen A, Kuoppala T, Tiikkainen M, Lehtinen T, Lehtovirta
P, Punnonen R, Vesterinen E, Paavonen J: Pre- and posttreatment serum
antibody response to HPV 16 E2 and HSV-2 ICP8 proteins in women with
cervical carcinoma. J Med Virol 37:180-186, 1992. IF 2.792
145. Cacciatore B, Leminen A, lngman-Friberg S, Ylöstalo P, Paavonen
J: Transvaginal sonographic findings in ambulatory patients with suspected
pelvic inflammatory disease. Obstet Gynecol 80:912-6, 1992. IF 2.427
146. Lehtinen M, Leminen A, Paavonen J, Lehtovirta P, Hyöty H,
Vesterinen E, Dillner J: Predominance of serum antibodies to synthetic
peptide stemming from HPV 18 open reading frame E2 in cervical adenocarcinoma.
J Clin Pathol 45:494-497, 1992. IF 1.581
147. Paavonen J: Genital Chlamydia trachomatis infections in the female.
J Infection 25(Suppl):39- 45, 1992. IF 1.298
148. Kulomaa P, Paavonen J, Lehtinen M: Herpes simplex virus induces
unscheduled DNA synthesis in virus-infected cervical cancer cell lines.
Research in Virology 143:351-359, 1992. IF 1.043
149. Lehtinen M, Stellato G, Hyöty H, Nieminen P, Vesterinen E,
Paavonen J: A T-helper cell epitope overlaps a major B-cell epitope
in human papillomavirus type 18 E2 protein. Acta Pathol Microbiol Scand
100:1022-6, 1992. IF 1.016
150. Stellato G, Nieminen P, Aho H, Vesterinen E, Vaheri A, Paavonen
J: Human papillomavirus infection of the female genital tract: correlation
of HPV DNA with cytologic, colposcopic, and natural history findings.
Eur J Gynecol Oncol 13:262-267, 1992.
151. Vesterinen E, Stellato G, Nieminen P, Soares VRX, Vaheri A, Paavonen
J: A prospective cohort study on the natural history of human papillomavirus
genital infection. B lst Tum Napoli 39:43-46, 1992.
152. Paavonen J, Weström LV: Diagnosis of pelvic inflammatory disease.
In: Pelvic Inflammatory Disease. GS Berger, LV Weström (eds.).
Raven Press, Ltd. New York, 1992, pp.49-78.
1993
153. Condyloma Collaborative Study Group: Randomized placebo-controlled
double-blind combined therapy trial with systemic interferon alfa-2a
and laser surgery in the treatment of anogenital condylomata acuminata.
J Infect Dis 167:824-9, 1993. IF 5.418
154. Hakama M, Lehtinen M, Knekt P, Aromaa A, Leinikki P, Miettinen
A, Paavonen J, Peto R, Teppo L: Serum antibodies and subsequent cervical
neoplasms: A prospective study with 12 years follow-up. Am J Epidemiol
137:166-170, 1993. IF 4.112
155. Mattila A, Miettinen A, Heinonen PK, Teisala K, Punnonen R, Paavonen
J: Detection of serum antibodies to Chlamydia trachomatis with chlamydial
and nonchlamydial pelvic inflammatory disease by the IPAzyme chlamydia
and enzyme immunoassay. J Clin Microbiol 31:998-1000, 1993. IF 3.964
156. Miettinen A, Laippala P, Heinonen PK, Paavonen J: Test performance
of serum C-reactive protein and erythrocyte sedimentation rate in assessing
the severity of acute pelvic inflammatory disease. Am J Obstet Gynecol
169: 1143-48, 1993. IF 2.642
157. Lehtinen M, Rantala 1, Luoto H, Aine R, Lauslahti K, Ylä-Outinen
A, Romppanen U, Paavonen J: Depletion of Langerhans cells in cervical
human papillomavirus infection is associated with viral replication
of the virus. Acta Pathol Microbiol Scand 101: 833-837, 1993. IF 1.016
158. Paavonen J: Pathophysiologic aspects of human papillomavirus infection.
Curr Opin Infect Dis 6:21-26, 1993. IF 0.935
159. Paavonen J: Chlamydia trachomatis-A major threat to reproduction.
Eur J Obstet Gyn Reprod Biol 49: 23-27, 1993. IF 0.537
160. Lehtinen M, Niemelä J, Dillner J, Parkkonen P, Nummi T, Liski
E, Nieminen P, Reunala T, Paavonen J: Evaluation of serum antibody response
to a newly identified B-cell epitope in the minor nucleocapsid protein
L2 of human papillomavirus type 1 6. Clin Diagn Virology 1:153-165,
1993.
161. Paavonen J: Cervicitis. In: Vulvovaginitis. M Elsner, J Martius
(eds.). Chapter 16. Marcel Dekker, Inc., New York, New York, 1993, pp.
385-398.
162. Lehtinen M, Dillner J, Aromaa A, R-K Aaran, Hakulinen T, Knekt
P, Leinikki P, Luostarinen T, Maatela J, Paavonen J, Hakama M: IgG antibodies
to human papillomavirus type 16 and serum retinol may jointly protect
against cervical neoplasia. In: Immunology of Human Papillomaviruses.
Stanley M (ed.), Plenum Publishing Company Ltd. London, 1 993.
163. Paavonen J: Chlamydia trachomatis infections in the female genital
tract. Advances in Gynecological and Obstetric Research Series. Volume
3. Recent Advances in Cervical Pathology and Colposcopy. The Proceedings
of the 7th World Congress of Cervical Pathology and Colposcopy. pp.
103- 109, 1993.
1994
164. Paavonen J, Lähdeaho M-L, Puolakkainen M, Parkkonen P, Mäki
M, Lehtinen M: Antibody response to B cell epitopes of Chlamydia trachomatis
60-kilodalton heat shock protein and corresponding mycobacterial and
human peptides. J Infect Dis 169:908-911, 1994. IF 5.418
165. Zheng J, Wahlström T, Paavonen J, Vaheri A: Altered growth
of human cervical epithelial cells transfected by HPV type 16 and 8
DNA. lnt J Cancer 58:713-720, 1994. IF 3.534
166. Nieminen P, Aho M, Vesterinen E, Vaheri A, Paavonen J: Treatment
of genital HPV infection with carbon dioxide laser and systemic interferon
alpha-2b. Sex Transm Dis 21:65-69, 1994. IF 1.894
167. Paavonen J, Nieminen P, Jalava T, Kallio A, Ranki M: Detection
of Human Papillomavirus DNA by AffiProbe HPV-DNA test kit in cervical
scrapes or biopsies-Histopathologic correlates. Infect Dis Obstet Gynecol
2:126-129, 1994.
168. Paavonen J, Lehtinen M: lmmunopathogenesis of chlamydial pelvic
inflammatory disease-the role of heat-shock proteins. Infect Dis Obstet
Gynecol 2:105-110, 1994.
169. Lehtinen M, Paavonen J. Heat-shock proteins in the immunopathogenesis
of chlamydial pelvic inflammatory disease. In: Chlamydial infections
(eds. J Orfila et al.). Societa Editrice Esculapio, Bologna, Italy,
pp. 599-610, 1994. ISBN 88-85040-92-6.
170. Paavonen J: Vulvodynia - the burning vulva syndrome. J Obstet Gynecol
14 (Suppl 2):S77-S81, 1994.
1995
171. Lehtinen M, Hibma MH, Stellato G, Kuoppala T, Paavonen J: Human
T helper cell epitopes overlap B cell and putative cytotoxic T cell
epitopes in the E2 protein of human papillomavirus type 16. Biochem
Biophys Res Communic 209:541-46, 1995. IF 2.872
172. Venesmaa P, Paavonen J, Forss M, Ylikorkala 0: Chemotherapy-changes
the DNA ploidy in ovarian cancer. Br J Obstet Gynecol 102:568-569, 1995.
IF 2.219
173. Paavonen J: Diagnosis and treatment of vulvodynia. Ann Med 27:175-81,
1995. IF 1.716
174. Paavonen J: Vulvodynia-A complex syndrome of vulvar pain. Acta
Obstet Gynecol Scand 74:243-247, 1995. IF 0.872
175. Paavonen J, Nieminen P, Lehtinen M: The role of non-HPV viruses
and other infectious factors in the etiology of cervical neoplasia.
In: Papillomavirus in Human Pathology. J Monsonego (ed.). Ares-Serono
Symposia Publications. Challenges of Modern Medicine 9:111-116, 1995.
176. Paavonen J: Concurrent genital infections recognized at colposcopy.
In: lntraepithelial Neoplasia of the Female Lower Genital Tract. Churchill
Livingstone, Edinburgh, United Kingdom, 1995. p. 349-355.
177. Stellato G, Paavonen J: A colposcopic scoring system for grading
cervical lesions. Eur J Gynaecol Oncol 16:296-300, 1995.
178. Stellato G, Paavonen J: Vulvar and vaginal colposcopic pictures
of human papillomavirus infection. Eur J Gynaecol Oncol 16:228-231,
1995.
179. Paavonen J: Chlamydia, gonorrhea, and reproductive health. Journal
of the Society of Obstetricians and Gynaecologists of Canada 17:1067-1075,
1995.
180. Paavonen J: Chlamydia trachomatis infections - is screening cost-effective?
Icelandic Med J 81:614-617, 1995.
181. Luomanen M, Meurman JH, Kosloff T, Paavonen J, Nieminen P, Pöllänen
R, Lukinmaa P-L. Mouth mucosa in patients suffering from genital condyloma
infections. Oral Surgery Oral Diagnosis 6:7-11, 1995.
1996
182. Sellors J, Paavonen J. Screening for chlamydia to prevent pelvic
inflammatory disease. N Engl J Med 335:1531-1532, 1996 (letter, peer
reviewed). IF 24.834
183. Lehtinen M, Dillner J, Knekt P, Luostarinen T, Aromaa A, Kirnbauer
R, Koskela P, Paavonen J, Peto R, Schiller JT, Hakama M. Serologically
diagnosed infection with human papillomavirus type 16 and risk for subsequent
development of cervical carcinoma: nested case-control study. Br Med
J 312:537-542, 1996. IF 4.947
184. lwasawa A, Nieminen P, Lehtinen M, Paavonen J: Human papillomavirus
DNA in uterine cervix squamous cell carcinoma and adenocarcinoma detected
by polymerase chain reaction. Cancer 77:2275-9, 1996. IF 3.296
185. lwasawa A, Nieminen P, Lehtinen M, Paavonen J: Human papillomavirus
in squamous cell carcinoma of the vulva by polymerase chain reaction.
Obstet Gynecol 89:81-84, 1996. IF 2.427
186. Paavonen J, Lehtinen M. Chlamydial pelvic inflammatory disease.
Human Reprod Update 2:519-529, 1996. IF 1.513
187. Paavonen J. lmmunopathogenesis of pelvic inflammatory disease and
infertility - what do we know and what shall we do? J Brit Fertil Soc
1:42-45, 1996.
188. Rice RJ, Schwartz DA, Knapp JS, Paavonen J: Pelvic Inflammatory
Disease: Epidemiology, clinical manifestations, treatment, and prevention
strategies. In: Atlas of Sexually Transmitted Diseases and AIDS, Stephen
A. Morse et al. (eds.), pp. 133-147. Mosby-Wolfe. ISBN 0-7234-2143-9.
189. Paavonen J. Chlamydia trachomatis - a major cause of mucopurulent
cervicitis and pelvic inflammatory disease in women. Current Problems
in Dermatology 24:110-22. Vol 24: Sexually Transmitted Diseases: Advances
in diagnosis and treatment, Elsner P, et al (eds), pp. 110-123, 1996.
ISBN 3-8055-6220- 9.
190. Mårdh P-A, Möller B, Paavonen J, Weström L. Pelvic
inflammatory disease. In: Atlas of Infectious Diseases (eds. Mandell
GA, Rein MF). Volume V:5.2-5.21, 1996. Paramount Printing Group Limited.
ISBN 0-443-07720-7.
191. Paavonen J. Chlamydia trachomatis infection and host response.
In: A. Templeton (Ed.) The Prevention of Pelvic Infection. Proceedings
of the 31 th Study Group of the Royal College of Obstetricians and Gynaecologists.
London: RCOG Press, 1996, p. 107-120.
192. Paavonen J, Puolakkainen M, Paukku M, Sintonen H. Screening for
Chlamydia trachomatis infections in low prevalence populations: an economic
and health benefit analysis. In: A. Templeton (Ed.) Prevention of Pelvic
Infection. Proceedings of the 31 th Study Group of the Royal College
of Obstetricians and Gynaecologists. London: RCOG Press, 1996, p. 181-189.
193. Stellato G, Lehtinen M, Paavonen J. Human papillomaviruses: general
features and genome organization. Cancer Rep 43:47-51, 1996.
194. Stellato G, Lehtinen M, Paavonen J. Host immune response to human
papilloma virus infection in the lower female genital tract. Cancer
Rep 43:53-56, 1996.
195. Stellato G, Lehtinen M, Paavonen J. Human papillomavirus infection
of the lower female genital tract: clinical aspects. Cancer Rep 43:57-64,
1996.
196. Stellato G, Lehtinen M, Paavonen J. Diagnostics of human papilloma
virus infection in the lower female genital tract. Cancer Rep 43:65-74,
1996.
197. Stellato G, Lehtinen M, Paavonen J. Treatment of lower female genital
tract human papilloma virus infections. Cancer Rep 43:75-87, 1996.
1997
198. Dillner J, Lehtinen M, Bjfrge T, Luostarinen T, Youngman L, Jellum
E, Koskela P, Abeler V, Hallmans G, Paavonen J, Schiller J, Hakulinen
T, Thoresen S, Hakama M. A prospective, seroepidemiological study of
human papillomavirus infection as risk factor for invasive cervical
cancer. J Natl Cancer Inst 89:1293-1299, 1997. IF 10.328
199. Bjorge T, Lehtinen M, Anttila T, Engeland A, Hakulinen T, Jellum
E, Luostarinen T, Paavonen J, Pukkala E, Sapp M, Schiller J, Thoresen
S, Youngman L, Dillner J. A prospective, seroepidemiological study of
the role of human papillomavirus in esophageal cancer in Norway. Cancer
Res 57:3989-3992, 1997. IF 8.958
200. Bjorge T, Dillner J, Anttila T, Engeland A, Hakulinen T, Jellum
E, Lehtinen M, Luostarinen T, Paavonen J, Pukkala E, Sapp M, Schiller
J, Youngman L, Thoresen S. A prospective seroepidemiological study of
the role of human papillomavirus in non-cervical anogenital cancers.
Br Med J 315:646-649, 1997. IF 4.947
201. Eschenbach DA, Wölner-Hanssen P, Hawes SE, Pavletic A, Paavonen
J, Holmes KK. Acute pelvic inflammatory disease: Associations of clinical
and laboratory findings with laparoscopic findings. Obstet Gynecol 89:184-92,
1997. IF 2.427
202. lwasawa A, Hiltunen-Back E, Reunala T, Nieminen P, Paavonen J.
Human papillomavirus DNA in urine specimens of men with Condyloma acuminatum.
Sex Transm Dis 24:165-168, 1997. IF 1.894
203. Paukku M, Puolakkainen M, Apter D, Hirvonen S, Paavonen J. First
void urine testing for Chlamydia trachomatis by polymerase chain reaction
in asymptomatic women. Sex Transm Dis 24:343-346, 1997. IF 1.894
204. Patel R, Bodsworth N J, Woolley P, Peters B, Vejlsgaard G, Saari
S, Gibb A, Robinson J, and the International Valaciclovir HSV Study
Group. Valociclovir for the suppression of recurrent genital HSV infection:
a placebo controlled study of once daily therapy. Genitourin Med 73:105-109,
1997. IF 1.604
205. Bodsworth NJ, Crooks RJ, Borelli S, Vejlsgaard G, Paavonen J, Worm
M, Uexkull N, Esmann J, Strand A, lngamelis AJ, Gibb A and the International
Valaciclovir HSV Study Group. Valaciclovir versus aciclovir in patient-initiated
treatment of recurrent genital herpes: a randomised, double-blind clinical
trial. Genitourin Med 73:110-116, 1997. IF 1.604
206. Paavonen J. Is screening for Chlamydia trachomatis infection cost-effective?
Genitourin Med 73:103-104, 1997. IF 1.604
207. Stellato G, Nieminen P, Aho M, Lehtinen T, Lehtinen M, Paavonen
J. Type 1 cytokine response and treatment outcome of genital HPV lesions.
Genitourin Med 73:387-90, 1997. IF 1.604
208. Paavonen J. Desquamative Inflammatory Vaginitis (DIV). Infect Dis
Obstet Gynecol 4:257,1997.
209. Stellato G, Paavonen J, Nieminen P, Hibma M, Vilja P, Lehtinen
M. Diagnostic phase antibody response to the human papillomavirus type
16 E2 protein is associated with succesful treatment of genital HPV
lesions with systemic interferon alpha-2b. Clin Diagn Virol 7:167-172,
1997.
1998
210. Domeika M, Domeika K, Paavonen J, Mårdh P-A, Witkin SS. Humoral
immune response to conserved epitopes of Chlamydia trachomatis and human
60-kDa heat-shock protein in women with pelvic inflammatory disease.
J Infect Dis 177:714-9, 1998. IF 4.966
211. Puolakkainen M, Hiltunen-Back E, Reunala T, Suhonen S, Lähteenmäki
P, Lehtinen M, Paavonen J. Comparison of performance of two commercially
available test, a PCR assay and ligase chain reaction tests, in detection
of urogenital Chlamydia trachomatis infection. J Clin Microbiol 36:1489-1493,
1998. IF 3.579
212. Chernesky M, Luinstra K, Sellors J, Schachter J, Moncada J, Caul
O, Paul I, Mikaelian L, Toye B, Paavonen J, Mahony J. Can serology diagnose
upper genital tract Chlamydia trachomatis infection? Studies on women
with pelvic pain, with or without chlamydial plasmid DNA in endometrial
biopsy tissue. Sex Transm Dis 25:14-19, 1998. IF 2.315
213. Hiltunen-Back E, Rostila T, Kautiainen H, Paavonen J, Reunala T.
Rapid decrease of endemic gonorrhea in Finland. Sex Transm Dis 25:181-186,
1998. IF 2.315
214. Venesmaa P, Stenman U-H, Forss M, Leminen A, Lehtovirta P, Vartiainen
J, Paavonen J. Preoperative serum level of tumor-associated trypsin
inhibitor (TATI) and residual tumor size as a prognostic indicator in
stage III epithelial ovarian cancer. Br J Obstet Gynecol 105:508-511,
1998. IF 2.299
215. Paavonen J, Puolakkainen M, Paukku M, Sintonen H: Cost-benefit
analysis of first-void urine Chlamydia trachomatis screening program.
Obstet Gynecol 92:292-298 1998. IF 2.252
216. Paavonen J. Pelvic inflammatory disease - from diagnosis to prevention
(a review) Dermatol Clin 16;747-756, 1998. IF 1.060
217. Paukku M, Närvänen A, Puolakkainen M, Dreesbach K, Hao
W, Saikku P, Paavonen J. Detection of serum antibodies to Chlamydia
trachomatis by rELISA and peptice based EIA in acute and chronic genital
infections. Int J STD & AIDS 9:604-607, 1998. IF 1.042
218. Hurskainen R, Teperi J, Turpeinen U, Grenman S, Kivelä A,
Kujansuu E, Vihko K, Yliskoski M, Paavonen J. Combined laboratory and
diary method for objective assesment of menstrual blood loss. Acta Obstet
Gynecol Scand 77:201-204, 1998. IF 0.974
219. Paavonen J. Diffuse laminar endocervical hyperplasia (DLEGH) or
Chlamydia trachomatis infection? Acta Obstet Gynecol Scand 77:873, 1988
(letter, peer reviewed). IF 0.974
220. Paavonen J. Chlamydia trachomatis infections - from diagnosis to
treatment and prevention (a review). In: RD Kempers, et al (Ed.) Fertility
and Reproductive Medicine. Elsevier Science B.V., Amsterdam, Netherlands,
1998 p. 497-509.
221. Paavonen J, Anttila T, Koskela P, Lehtinen M, and Nordic Serum
Bank Study Group. Chlamydia trachomatis and cervical cancer. In: R.S.
Stephens, et al (Ed.) Chlamydial Infections. Proceedings of the 9th
International Symposium on Human Chlamydial Infection, 1998 p. 39-42.
222. Puolakkainen M, Paukku M, Nikkari S, Paavonen J, Suni J, Vaheri
A, Närvänen A. Performance of a peptide-based enzyme immunoassay
for Chlamydia trachomatis antibodies. In: R.S. Stephens, et al (Eds.)
Chlamydial Infections. Proceedings of the 9th International Symposium
on Human Chlamydial Infections, 1998 p.635-638.
223. Paavonen J. The importance of Chlamydia trachomatis screening in
cost-benefit consideration. Clinician 16:2-6, 1998.
224. Paavonen J. Chlamydia and cancer. Gynecol Forum 3; 17-20, 1998.216.
1999
225. Kekki M, Kurki T, Paavonen J, Rutanen E-M. Insulin-like growth
factor binding protein-1 in cervix as a marker of infectious complications
in pregnant women with bacterial vaginosis. Lancet 353:1494, 1999. IF
11.793
226. Tukeva TA, Aronen HJ, Karjalainen PT, Molander P, Paavonen T, Paavonen
J. MR imaging in pelvic inflammatory disease: Comparison with laparoscopy
and US. Radiology 210:209-216, 1999. IF 4.753
227. Airenne S, Surcel H-M, Alakärppä H, Laitinen K, Paavonen
J, Saikku P, Laurila A. Chlamydia pneumoniae infection in human monocytes.
Infect Immun 67:1445-1449, 1999. IF 4.034
228. Paavonen J, Eggert-Kruse W. Chlamydia trachomatis - impact on human
reproduction. Hum Reprod Update 5:433-447, 1999. IF 3.651
229. Hurskainen R, Teperi J, Paavonen J, Cacciatore B. Menorrhagia and
uterine artery blood flow. Hum Reprod 14:186-189, 1999. IF 3.650
230. Paukku M, Tulppala M, Puolakkainen M, Anttila T, Paavonen J. Lack
of association between serum antibodies to Chlamydia trachomatis infection
and history of recurrent pregnancy loss Fertil Steril 72:427-430, 1999.
IF 3.344
231. Luostarinen T, af Geijersstam V, Bjfrge T, Eklund C, Hakama M,
Hakulinen T, Jellum E, Koskela P, Paavonen J, Pukkala E, Schiller T,
Thoresen S, Youngman LD, Dillner J, Lehtinen M. No excess risk of cervical
carcinoma among women seropositive for both HPV16 and HPV6/11. Int J
Cancer 80:818- 822, 1999. IF 3.283
232. Paukku M, Puolakkainen M, Paavonen T, Paavonen J. Plasma cell endometritis
is associated with Chlamydia trachomatis infection. Am J Clin Pathol
112:211-215, 1999. IF 2.635
233. Arvaja M, Lehtinen M, Koskela P, Lappalainen M, Paavonen J, Vesikari
T. Serological evaluation of herpes simplex virus type 1 and type 2
infections in pregnancy Sex Transm Inf 75:168-171, 1999. IF 1.782
234. Paavonen J. Sexual dysfunction associated with treatment of cervical
cancer. Sex Transm Inf 75:375-376, 1999. IF 1.782
235. Paavonen J, Lehtinen M. Interactions between HPV and other sexually
transmitted agents in the etiology of cervical cancer Curr Opin Infect
Dis 12:67-71, 1999. IF 0.874
236. Kiviat N, Koutsky LA, Paavonen J. Cervical neoplasia and other
STD-related genital tract neoplasias. In: Holmes KK, et al (Eds.) Sexually
transmitted diseases. McGraw-Hill, New York, 3. edition, 1999 p.811-831.
237. Pavletic AJ, Eschenbach DA, Wölner-Hanssen P, Paavonen J,
Hawes SE, Holmes KK. Infertility following pelvic inflammatory disease.
Infect Dis Obstet Gynecol 7:145-152, 1999.
238. Kekki M, Kurki T, Kurkinen-Räty M, Pelkonen J, Paavonen J.
Recurrent bacterial vaginosis in pregnancy predisposes to infectious
morbidity: a double-blind, placebo-controlled multicenter intervention
trial with vaginal clindamycin (abstract). Int J Gynecol Obstet (suppl.1)
67:S42, 1999.
239. Kekki M, Kurki T, Paavonen J, Kärkkäinen T, Rutanen E-M.
IGFBP-1 in cervix as a predictor of prognosis in the patients with early
pregnancy BV (abstract). Int J Gynecol Obstet (suppl.1) 67:S46, 1999.
2000
240. van Benthem B.H.B., Prins M, Larsen C, Delmas M-C, Brunet J-B,
van den Hoek A, for the European Study on the Natural History of HIV
Infection in Women. Sexually transmitted infections in European HIV-infected
women: incidence in relation to time from infection. AIDS 14:595-603,
2000. IF 6.931
241. Delmas M-C, Larsen C, Hamers F, Anzén B, Bergeron C, Meier
F, Peña JM, Poveda J-D, Serandeo D, Suligoi B, Van den Hoek A,
Vernezza P, Brunet J-B, De Vincenzi I, for the European Study on the
Natural History of HIV Infection in Women. Cervical squamous cell intraepithelial
lesions in HIV- infected women: prevalence, incidence and regression.
AIDS 14:1775-1784, 2000. IF 6.931
242. van Benthem BHB, de Vincenzi I, Delmas M-C, Larsen C, van den Hoek
A, Prins M, for the European Study on the Natural History of HIV Infection
in Women. Pregnancies before and after HIV diagnosis in a European cohort
of HIV infected women. AIDS 14:2171-2178, 2000. IF 6.931
243. Mosorin M, Surcel H-M, Laurila A, Lehtinen M, Karttunen R, Juvonen
J, Paavonen J, Morrison R, Saikku P, Juvonen T. Detection of Chlamydia
pneumoniae reactive T lymphocytes in human atherosclerotic plagues of
carotid artery. Arterioscler Thromb Vasc Biol 20:1061-1067, 2000. IF
5.406
244. Carlson P, Richardson M, Paavonen J. Evaluation of the Oricult-N
dipslide for laboratory diagnosis of vaginal candidiasis J Clin Microbiol
38:1063-1065, 2000. IF 3.670
245. Hurskainen R, Salmi A, Paavonen J, Teperi J, Rutanen E-M. Expression
of sex steroid receptors and Ki-67 in the endometria of menorrhagic
women: effects of intrauterine levonorgestrel Mol Hum Reprod 6:1013-1018,
2000. IF 3.643
246. Koskela P, Anttila T, Björge T, Brunsvig A, Dillner J, Hakama
M, Hakulinen T, Jellum E, Lehtinen M, Lenner P, Luostarinen T, Pukkala
E, Saikku P, Thoresen S, Youngman L, Paavonen J. Chlamydia trachomatis
infection and invasive cervical cancer. Int J Cancer 85:35-39, 2000.
IF 3.545
247. Kinnunen A, Molander P, Laurila A, Rantala I, Morrison R, Lehtinen
M, Karttunen R, Tiitinen A, Paavonen J, Surcel H-M. Chlamydia trachomatis
reactive T lymphocytes from upper genital tract tissue specimens Hum
Reprod 15:1484-1489, 2000. IF 3.003
248. Kurkinen-Räty M, Vuopala S, Koskela M, Kekki M, Kurki T, Paavonen
J, Jouppila P. A randomised controlled trial of vaginal clindamycin
for early pregnancy bacterial vaginosis. Br J Obstet Gynecol 107:1427-1432,
2000. IF 2.657
249. Kibur M, af Geijerstamm V, Pukkala E, Koskela P, Luostarinen T,
Paavonen J, Schiller J, Wang Z, Dillner J, Lehtinen M. Attack rates
of human papillomavirus type 16 and cervical neoplasia in primiparous
women and field trial designs for post-natal HPV16 vaccination. Sex
Transm Inf 76:13-17,2000. IF 2.136
250. Paavonen J. Memorable Chlamydia trachomatis papers. Sex Transm
Inf 76:S30-S32 (Suppl I), 2000. IF 2.136
251. Paavonen J, Mangioni C, Martin M, Wajszczuk CP. Vaginal clindamycin
and oral metronidazole for bacterial vaginosis: A randomized trial.
Obstet Gynecol 96:256-260, 2000. IF 2.122
252. Tuuminen T, Palomäki P, Paavonen J.The use of serologic tests
for the diagnosis of chlamydial infections. J Microbiol Methods 42:265-279,
2000. IF 1.303
253. Molander P, Cacciatore B, Sjöberg J, Paavonen J. Laparoscopic
management of acute pelvic inflammatory disease. J Am Assoc Gyn Lap
7:107-110, 2000. IF 0.780
254. Leminen A, Forss M, Paavonen J. Wound complications in patients
with carcinoma of the vulva. Comparison between radical and modified
vulvectomies. Eur J Obstet & Gynecol Reprod Biol 93:193- 197, 2000.
IF 0.776
255. Paavonen J, Halttunen M, Hansson P, Nieminen P, Rostila T, Lehtinen
M. Prerequisites for human papillomavirus vaccine trial. Results of
feasibility studies. J Clin Virol 19:25-30, 2000. IF 0.619
2001
256. Anttila T, Saikku P, Koskela P, Bloigu A, Dillner J, Ikäheimo
I, Jellum E, Lehtinen M, Lenner P, Hakulinen T, Närvänen A,
Pukkala E, Thoresen S, Youngman L, Paavonen J. Serotypes of Chlamydia
trachomatis and risk for cervical squamous cell carcinoma JAMA 285:47-51,
2001. IF 15.402
257. Anttila T, Koskela P, Lehtinen M, Dillner J, Paavonen J. Chlamydia
trachomatis and Cervical squamous cell carcinoma. JAMA 285:1705-1706,
2001 (Letter to the Editor) IF 15.402
258. Hurskainen R, Teperi J, Rissanen P, Aalto A-M, Grenman S, Kivelä
A, Kujansuu E, Vuorma S, Yliskoski M, Paavonen J. Quality of life and
cost-effectiveness of levanogestrel-releasing intrauterine system versus
hysterectomy for treatment of menorrhagia: a randomised trial. Lancet
357:273-277, 2001. IF 10.232
259. Hurskainen R, Paavonen J, Rissanen P, Teperi J. Treatment of menorrhagia.
Lancet 357:1886- 1887, 2001 (Letter, peer reviewed). IF 10.232
260. Hiltunen-Back E, Haikala O, Kautiainen H, Paavonen J, Reuala T.
A nationwide sentinel clinic survey of chlamydia trachomatis infection
in Finland. Sex Transm Dis 28;252-258, 2001. IF 3.021
261. Lehtinen M, Dillner J, Paavonen J. Vaccinating women against premature
death. Summary of an International Workshop, Helsinki, Finland, 10.01.2000.
Vaccine 19:1347-1352, 2001. IF 2.476
262. Hurskainen R, Aalto A-M, Teperi J, Grenman S, Kivelä A, Kujansuu
E, Vuorma S, Yliskoski M, Paavonen J. Psychosocial and other characteristics
of women complaining of menorrhagia, with and without actual increased
menstrual blood loss. Br J Obstet Gynecol 108:281-285, 2001. IF 2.349
263. Paavonen J. Chlamydia trachomatis and cancer. Sex Transm Inf 77:154-156,
2001. IF 2.136
264. van Bethem BHB, Spaargaren J, van den Hoek JAR, Merks J, Coutinho
RA, Prins M and the European Study on the Natural History of HIV infection
in women. Prevalence and risk factors of HSV-1 and HSV-2 antibodies
in European HIV infected women. Sex Transm Inf 77:120-124, 2001. IF
2.136
265. Kekki M, Kurki T, Pelkonen J, Kurkinen-Räty M, Cacciatore
B, Paavonen J. Vaginal clindamycin in preventing of preterm birth and
peripartal infections in asymptomatic women with bacterial vaginosis:
A randomized controlled trial. Obstet Gynecol 97:643-648, 2001. IF 2.091
266. Kinnunen A, Paavonen J, Surcel H-M. Heat shock protein 60 specific
T-cell response in chlamydial infections Scand J Immunol 54:76-81, 2001.
IF 1.777
267. Lehtinen M, Luukkaala T, Wallin K-L, Paavonen J, Thoresen S, Dillner
J, Hakama M. Human papillomavirus infection, risk for subsequent development
of cervical neoplasia andassociated population attribute fraction. J
Clin Virol 22:117-124, 2001. IF 1.744
268. Molander P, Sjöberg J, Paavonen J, Cacciatore B. Transvaginal
power Doppler findings in laparoscopically proven acute pelvic inflammatory
disease. Ultrasound Obstet Gynecol 17:233-238, 2001. IF 1.725
269. Aaltonen L-M, Auvinen E, Dillner J, Lehtinen M, Paavonen J, Rihkanen
H, Vaheri A. Poor antibody response against human papillomavirus in
adult-onset laryngeal papillomatosis. J Med Microbiol 50:468-471, 2001.
IF 1.625
270. Tukeva T, Salmi H, Poutanen V-P, Karjalainen P, Hytinantti T, Paavonen
J, Teramo K, Aronen H. Fetal shoulder measurements by fast and ultrafast
MRI techniques. J Magn Res Imaging 13:938-942, 2001. IF 1.302
271. Lonka K, Slotte V, Halttunen M, Kurki T, Tiitinen A, Vaara L, Paavonen
J. Portfolio as a learning tool in obstetrics and gynecology undergraduate
training. Med Educ 35:1125-1130, 2001. IF 1.078
272. Kekki M, Kurki T, Kärkkäinen T, Hiilesmaa V, Paavonen
J, Rutanen E-M. Insulin-like growth factor-binding protein-1 in cervical
secretion as a predictor of preterm delivery. Acta Obstet Gynecol Scand
80:546-551, 2001. IF 1.028
273. Lehtinen M, Paavonen J. Efficacy of preventive human papillomavirus
vaccination. Int J STD & AIDS 12:771-776, 2001. IF 1.019
274. Paavonen J. Pelvic inflammatory disease. Medicine 29:8:48-51, 2001.
275. Paavonen J. Cervicitis (a review). In: Faro S, Soper DE (Eds.)
Infectious Diseases in Women. WB Saunders Co. Philadelphia 2001, p.
261-266.
2002
276. van Benthem BHB, Vernezza P, Coutinho RA, Prins M for the European
Study on the Natural History of Women and the Swiss HIV Cohort Study.
The impact of pregnancy and menopause on CD4 lymphocyte counts in HIV-infected
women. AIDS 16:919-924, 2002. IF 8.018
277. Wallin K-L, Wiklund F, Luostarinen T, Ångström T, Anttila
T, Bergman F, Hallmans G, Ikäheimo I, Koskela P, Lehtinen M, Stendahl
U, Wadell G, Paavonen J, Dillner J. A population-based prospective study
of Chlamydia trachomatis infection and cervicalcarcinoma. Int J Cancer
101:371-374, 2002. IF 3.918
278. Kinnunen A, Surcel H-M, Lehtinen M, Karhukorpi J, Tiitinen A, Halttunen
M, Bloigu A, Kivelä H, Morrison R, Koskela P, Karttunen R, Paavonen
J. HLA DQ alleles and interleukin-10 polymorphism associated with Chlamydial
trachomatis-related tubal factor infertility: A case-control study.
Human Reprod 17:2073-2078, 2002. IF 2.997
279. Wilson JS, Honey E, Templeton A, Paavonen J, Mårdh P-A, Stary
A, Stray-Pedersen B. A systematic revview of the prevalence of Chlamydia
trachomatis among European women. Hum Reprod Update 8:385-394, 2002.
IF 2.969
280. Kinnunen A, Molander P, Morrison R, Lehtinen M, Karttunen R, Tiitinen
A, Paavonen J, Surcel H-M. Chlamydial heat shock protein 60 - specific
T cells in inflamed salpingeal tissue. Fertil Steril 70:162-166, 2002.
IF 2.854
281. Eckert LO, Hawes SE, Wölner-Hanssen P, Kiviat NB, Wasserheit
JN, Paavonen J, Eschenbach DA, Holmes KK. Endometritis: the clinical-pathological
syndrome. Am J Obstet Gynecol 186:690-695, 2002. IF 2.519
282. Honey E, Augood C, Templeton A, Russell I, Paavonen J, Mårdh
P-A, Stary A, Stray-Pedersen B. Cost effectiveness of screening for
chlamydia trachomatis: a review of published studies. Sex Transm Inf
78:406-412, 2002. IF 2.306
283. Inki P, Hurskainen R, Palo P, Ekholm E, Grenman S, Kivelä
A, Kujansuu E, Teperi J, Yliskoski M, Paavonen J. Comparison of ovarian
cyst formation in women using the levonorgestrel-releasing intrauterine
system vs. hysterectomy. Utrasound Obstet Gynecol 20:381-385, 2002.
IF 1.725
284. Molander P, Paavonen J, Sjöberg J, Savelli L, Cacciatore B.
Transvaginal sonography in the diagnosis of acute appendicitis. Ultrasound
Obstet Gynecol 20:496-501, 2002. IF 1.725
285. Strand A, Barton S, Alomar A, Kohl P, Kroon S, Moyal-Barracco M,
Munday P, Paavonen J, Volpi A. Current treatments and perceptions of
genital herpes: a European-wide view. J Eur Acad Dermatol Venereol 16:564-572,
2002. IF 0.981
286. Lehtinen M, Paavonen J, Vonka V. Human papillomavirus infection
of the cervix: its transmission, management during pregnancy and future
vaccine developments. In: European Practice in Gynecology and Obstetrics:
Viral infection in pregnancy. Donders G et al (eds.), Elsevier Sciense,
p. 168-178.
287. Stray-Pedersen B, Paavonen J. Clincial management of genital herpes
in women. In: European Practice in Gynaeclogy and Obstetrics: Viral
Infection in Pregnancy. Donders G et al. (eds.), Elsevier Science, p.
131-145.
2003
289. Anttila T, Koskela P, Leinonen M, Laukkanen P, Hakulinen T, Lehtinen
M, Pukkala E, Paavonen J, Saikku P. Chlamydia pneumoniae infection and
the risk of female early-onset lung cancer. Int J Cancer 107:681-682,
2003. IF 4.375
290. Lehtinen M, Pawlita M, Zumbach K, Abeler V, Hakama M, Jellum E,
Koskela P, Luostarinen T, Paavonen J, Pukkala E, Sigstad E, Thoresen
S, Dillner J. Evaluation of antibody response to human papillomavirus
early proteins in women who developed cervical cancer 1-20 years later.
Am J Obstet Gynecol 188:49-55, 2003. IF 2.518
291. Paavonen J, Karunakaran KP, Noguchi Y, Anttila T, Bloigu A, Dillner
J, Hallmans G, Hakulinen T, Jellum E, Koskela P, Lehtinen M, Thoresen
S, Lam H, Shen C, Brunham RC. Serum antibody response to the heat shock
protein 60 of Chlamydia trachomatis in women with developing cervical
cancer. Am J Obstet Gynecol 189:1287-1292, 2003. IF 2.518
292. Molander P, Finne P, Sjöberg J, Sellors J, Paavonen J. Observer
agreement study of laparoscopic diagnosis of pelvic inflammatory disease
using photographs. Obstet Gynecol 101:875-880, 2003. IF 2.957
293. Paukku M, Kilpikari R, Puolakkainen M, Oksanen H, Apter D, Paavonen
J. Criteria for selective screening for Chlamydia trachomatis. Sex Transm
Dis 30:120-123, 2003. IF 2.243
294. Hiltunen-Back E, Haikala O, Kautiainen H, Ruutu P, Paavonen J,
Reunala T. Nationwide increase of Chlamydia trachomatis infection in
Finland: highest rise among adolecent women and men. Sex Transm Dis
30:737-741, 2003. IF 2.243
295. Kinnunen A, Surcel H-M, Halttunen M, Tiitinen A, Morrison RP, Morrison
SG, Koskela P, Lehtinen M, Paavonen J. Chlamydia trachomatis heat shock
protein-60 induced interferon-? and interleukin-10 production in infertile
women. Clin Exp Immunol 131:299-303, 2003. IF 2.347
296. Hurskainen R, Paavonen J, Teperi J. The effectiveness of the levonorgestrel-releasing
intrauterine system in menorrhagia: a systematic review. Br J Obstet
Gynaecol 2003;110:83-93. IF 1.991
297. Lehtinen M, Paavonen J. Effectiveness of preventive human papillomavirus
vaccination. Int J STD & AIDS 14:787-792,2003. IF 1.359
298. Paavonen J, Schwarz D. Pelvic Inflammatory Disease. In: Atlas of
Sexually Transmitted Diseases and AIDS, 3rd edition. Stephen A. Morse
et al. (eds.), Elsevier Science 2003, 141-157.
299. Paavonen J, Molander P. Pelvic Inflammatory Disease. In: Gynecology,
3rd edition. Robert W Shaw, et al. (eds.), Elsevier Science 2003, p.
891-900.
300. Andersen ES, Paavonen J, Murnaghan M, Östör AG, Hanselaar
AG, Bergeron C, Dobbs SP.
Epithelial tumours. In: WHO Classification of Tumours: Tumours of the
Breast and Female Genital Organs. Tavassoli and Devilee (eds.). IARC
Press, Lyon 2003: 293-301.
2004
301. Corey L, Wald A, Patel R, Sacks SL, Tyring SK, Warren T, Douglas
JM, Paavonen J, Morrow A, Beutner KR, Stratchounsky LS, Mertz G, Keene
ON, Watson HA, Tait D, Vargas-Cortes M, for the Valaciclovir HSV Transmission
Study Group. Once daily valaciclovir to reduce the risk of the transmission
of genital herpes. N Engl J Med 350:11-20,2004. IF 34.833
302. Hurskainen R, Teperi J, Rissanen P, Aalto A-M, Grenman S, Kivelä
A, Kujansuu E, Vuorma S, Yliskoski M, Paavonen J. Clinical outcomes
and costs with the levonorgestrel-releasing intrauterine system or hysterectomy
for treatment of menorrhagia: randomised trial 5-year follow-up. JAMA
291:1436-1463, 2004. IF 21.455
303. Lehtinen M, Paavonen J. Vaccination against human papillomaviruses
shows great promise. Lancet 364:1731-1732, 2004. IF 18.316
304. Hinkula M, Pukkala E, Kyyrönen P, Laukkanen P, Koskela P,
Paavonen J, Lehtinen M, Kauppila A. A population-based study on the
risk of cervical cancer and cervical intraepithelial neoplasia among
grand multiparous women in Finland. Br J Cancer 90:1025-1029, 2004.
IF 3.894
305. Luostarinen T, Lehtinen M, Bjørge T, Abeler V, Hakama M,
Hallmans G, Jellum E, Koskela P, Lenner P, Lie AK, Paavonen J, Pukkala
E, Saikku P, Sigstad E, Thoresen S, Youngman LD, Dillner J, Hakulinen
T. Joint effects of different HPV and Chlamydia trachomatis infections
on risk of squamous cell carcinoma of the cervix uteri. Eur J Cancer
40:1058-1065, 2004. IF 3.694
306. Halmesmäki K, Hurskainen R, Tiitinen A, Teperi J, Greman S,
Kivelä A, Kujansuu E, Yliskoski M, Paavonen J. A randomised controlled
trial of hysterectomy or levonorgestrel-releasing intrauterine system
in the treatment of menorrhagia effect on FSH and menopausal
symptoms. Hum Reprod 19:378-382, 2004. IF. 3.125
307. Hurskainen R, Paavonen J. Levonorgestrel-releasing intrauterine
system in the treatment of heavy menstural bleeding. Curr Opin Obstet
Gynecol 16:487-490, 2004. IF 1.594
308. Tjalma WAA, Arbyn M, Paavonen J, van Waes TR, Bogers JJ. Prophylatictic
human papillomavirus vaccines: the beginning of the end of cervical
cancer. Int J Gynecol Cancer 14:751-761, 2004. IF 1.561
309. Kekki M, Kurki T, Kotomäki T, Sintonen H, Paavonen J. Cost-effectiveness
of screening and treatment for bacterial vaginosis in early pregnancy
among women at low risk for preterm birth. Acta Obstet Gynecol Scand
83:27-36, 2004. IF 1.166
310. Hurskainen R, Teperi J, Aalto A-M Grenman S, Kivelä A, Kujansuu
E Vuorma S, Yliskoski M, Rissanen P, Paavonen J. Levonorgestrel-releasing
intrauterine system or hysterectomy in the treatment of essential menorrhagia:
predictors of outcome. Acta Obstet Gynecol Scand 83:401-403, 2004. IF
1.166
311. Haanpää M, Paavonen J. Transient urinary retention and
chronic neuropathic pain associated with genital herpes simplex virus
infection. Acta Obstet Gynecol Scand 83:946-949, 2004. IF 1.166
2005
312. Lehtinen M, Ögmundsdottir HM, Bloigu A, Hakulinen T, Hemminki
E, Gudnadottir M, Kjartansdottir A, Paavonen J, Pukkala E, Tulinius
H, Lehtinen T, Koskela P. Associations between three types of maternal
bacterial infections and risk of leukemia in the offsprings. Am J Epidemiol
162:662-667, 2005. IF 4.933
313. Rana RK, Pimenta JM, Rosenberg DM, Tyring SK, Paavonen J, Cook
SF, Robinson NJ; the Valaciclovir HSV Transmitton Study Group. Demographic,
behavioral and knowledge factors associated with herpes simplex virus
type 2 infection among men whose female partner has genital herpes.
Sex Transm Dis 32:308-313, 2005. IF 2.081
314. Lehtovirta P, Skogberg K, Salo E, Ämmälä P, Ristola
M, Suni J, Paavonen J, Heikinheimo O. Pregnancy outcome among HIV-infected
women in the Helsinki metropolitan area. Acta Obstet Gynecol Scand 84:945-950,
2005 IF 1.324
315. Auvinen E, Niemi M, Malm C, Zilliacus R, Trontti A, Fingerroos
R, Lehtinen M, Paavonen J. High prevalence of HPV among female students
in Finland. Scand J Infect Dis 37:873-876, 2005 IF 1.141
316. Aaltonen L-M, Cajanus S, Bäck L, Nieminen P, Paavonen J, Ranki
A. Extralaryngeal HPV infections in male patients with adult-onset laryngeal
papillomatosis. Eur Arch Otorhinolaryngol 262:708-712, 2005. IF 0.673
317. Oittinen J, Kurki T, Kekki M, Kuusisto M, Pussinen P, Vilkuna-Rautiainen
T, Nieminen A, Asikainen A, Paavonen J. Periodontal disease and bacterial
vaginosis increase the risk for adverse pregnancy outcome. Infect Dis
Obstet Gynecol 13:213-216, 2005.
318. Paavonen J, Lehtinen M. First-generation vaccines against human
papillomavirus. Women’s Health 1:223-229, 2005.
319. Paavonen J. Pelvic inflammatory disease. Medicine (33:10) 43-46,
2005.
2006
320. Öhman H, Tiitinen A, Halttunen M, Birkelund S, Christiansen
G, Koskela P, Lehtinen M, Paavonen J, Surcel H-M. IL-10 polymorphism
and cell mediated immune response to chlamydia trachomatis Genes and
Immunity (in press). IF 3.718
321. Tiitinen A, Surcel H-M, Halttunen M, Birkelund S, Bloigu A, Christiansen
G, Koskela P, Morrison R, Paavonen J. Chlamydia trachomatis specific
antibody and cell mediated responses predicting tubal factor infertility.
Hum Reprod (in press) IF 3.365
322. Riska A, Finne P, Alfthan H, Anttila T, Jalkanen J, Sorvari T,
Stenman UH, Paavonen J, Leminen A. Chlamydial infection and risk of
primary fallopian tube carcinoma. Eur J Cancer (in press). IF 3.302
323. Paavonen J. Sexually transmitted chlamydial infections and subfertility
Fertil Steril (in press).
IF 3.170
324. Lehtinen M, Paavonen J. Controlling common sexually transmitted
infection in adolescents – time for rethinking. Sex Transm Inf
(in press) IF 2.204
325. Lehtinen M, Idänpään-Heikkilä I, Lunnas T,
Palmroth J, Barr E, Cacciatore R, Isaksson R, Kekki M, Koskela P, Kosunen
E, Kuortti M, Lahti L, Liljamo T, Luostarinen T, Apter D, Pukkala E,
Paavonen J. Population based enrolment of adolescents in a long-term
follow-up trial of human papillomavirs vaccine efficacy. Int J STD &
AIDS (in press) IF 1.506
326. Lehtovirta P, Finne P, Nieminen P, Skogberg K, Savonius H, Paavonen
J, Heikinheimo O. Prevalence and risk factors of squamous intraepithelial
lesions of the cervix among HIV-infected women – a long-term follow-up
study in a low prevalence population. Int J STD & AIDS (in press).
IF 1.506
327. Tikkanen M, Nuutila M, Hiilesmaa V, Paavonen J, Ylikorkala O. Prepregnancy
risk factors for placental abruption. Acta Obstet Gynecol Scand (in
press). IF 1.324
328. Tikkanen M, Nuutila M Hiilesmaa V, Paavonen J, Ylikorkala O. Clinical
presentation and risk factors of placental abruption. Acta Obstet Gynecol
Scand (in press). IF 1.324
329. Buck HW, Fortier M, Paavonen J. Imiquimod 5% cream in the treatment
of anogenital warts in female patients; efficacy of initial and repeated
therapy Int J Gynecol Obstet (in press). IF 0.754
330. Paavonen J. Sexually transmitted diseases in pregnancy. In: Schachter
J, Hook EW, McCormack W, Rice PA, Chernesky MA, Morse SA, Paavonen J.
(Eds.) Practical Guide to Sexually Transmitted Diseases. Churchill Livingstone,
New York (in press).
331. Paavonen J. Strategies for prevention of sexually transmitted infections
in Europe. In: Contraception in the Third Millenium: A Revolution in
reproductive and sexual health. Proceedings of the 6th Congress of the
European Society of Contraception. Parthenon Publishing (in press).
332. Paavonen J. Vulvodynia. In: Kunnamo I, et al, eds. Evidence-Based
Medicine Guidelines. Chichter, John Wiley & Sons, 2005 (in press).
333. Paavonen J, Lehtinen M. Prophylactic human papillomavirus vaccine.
Women’s Health 2:5-6, 2006.
334. Paavonen J. Vestibulitis – concervative treatment or surgery?
Progress in Obstetrics and Gynecology. Churchill Livingstone (in press).
335. Paavonen J. Vulvodynia: a therapeutic challenge. Women's Health
(in press).